Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Risk Factor 1

Another defendant may be Moore.

Our last license signing was in March 2010. Our litigation against TPL announcement was in april 2010. Moore announced his unsuccessful arbitration attempt about the same time. He may have joined forces with us at that time.

Thanks

Share
New Message
Please login to post a reply